NCT05980104 is a NA clinical trial of Empowered Relief in Chronic Pain, sponsored by Stanford University.

Who is sponsoring NCT05980104?

NCT05980104 is sponsored by Stanford University.

What drugs are being tested in NCT05980104?

Interventions in NCT05980104: Empowered Relief.

What condition does NCT05980104 study?

NCT05980104 studies Chronic Pain, Marfan Syndrome, Vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome.

Is NCT05980104 still recruiting?

NCT05980104 is currently completed. Last updated 26 October 2024.

Last reviewed 2024-10-26 · How we verify

NCT05980104

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single-Session "Empowered Relief" Class for Marfan Syndrome and Related Conditions

Completed NA Last updated 26 October 2024

What this trial tests

NA trial testing Empowered Relief in Chronic Pain in 92 participants. Completed in 31 August 2024.

Timeline

21 March 2024

Primary endpoint
31 August 2024

31 August 2024

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	92
Start date	21 March 2024
Primary completion	31 August 2024
Estimated completion	31 August 2024
Sites	1 location across United States

Drugs / interventions tested

Empowered Relief

Conditions studied

Chronic Pain — all drugs for Chronic Pain →
Marfan Syndrome — all drugs for Marfan Syndrome →
Vascular Ehlers-Danlos Syndrome — all drugs for Vascular Ehlers-Danlos Syndrome →
Loeys-Dietz Syndrome — all drugs for Loeys-Dietz Syndrome →

Sponsor

Stanford University

Who can join

18 and older, any sex, with Chronic Pain or Marfan Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Empowered Relief (ER) is a 1-session pain relief skills intervention that is delivered in-person or online by certified clinicians to groups of patients with acute or chronic pain. Prior work in has shown ER efficacy for reducing chronic pain, pain-related distress, and other symptoms 6 months post-treatment. The purpose of this study is to conduct the first feasibility and early efficacy test of online ER (two hours total treatment time) delivered to individuals with Marfan syndrome, Vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, and related conditions. Participants will be followed for 3 months via 5 follow-up surveys.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Online 1-session Empowered Relief in Marfan syndrome and related diseases: a single-arm feasibility and pilot efficacy study.
Perez L, Palenski P, Monson EA, Contreras L, et al · · 2026 · cited 2× · PMID 41495090 · DOI 10.1038/s41598-025-29943-x

Verify or expand the search:

Other trials of Empowered Relief

Trials testing the same drug.

NCT07406997 — Rehabilitation With Empowered STrategies to Optimize REcovery · NA · recruiting
NCT07193095 — This Project is a Three-arm RCT Evaluating Two, Single-session Behavioral Interventions for Adults With Chronic Musculos · NA · recruiting
NCT06940986 — The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System · NA · not yet recruiting
NCT04546685 — Virtual 1-Session Spanish "Empowered Relief" Group Intervention for Chronic Pain · NA · recruiting
NCT06443164 — Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery · NA · enrolling by invitation

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05980104 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 26 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05980104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing